Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2014
Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonistKlaus Linz, Thomas Christoph, Thomas M Tzschentke, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2019
Discovery of indane propanamides as potent and selective TRPV1 antagonistsSongyeon Ahn, Yong Soo Kim, Myeong Seup Kim, et al.
European Journal of Pharmacology|April 4, 2022
A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregenerationPetra Bloms-Funke, Michael Schumacher, Song Liu, et al.
Bioorganic & Medicinal Chemistry|March 19, 2017
t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsSunho Lee, Dong Wook Kang, HyungChul Ryu, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 13, 2019
Occurrence of Gastrointestinal Parasites in Small Mammals from GermanyDiana Riebold, Kati Russow, Mathias Schlegel, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: CebranopadolStefan Schunk, Klaus Linz, Claudia Hinze, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor AgonistsStefan Schunk, Klaus Linz, Sven Frormann, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2013
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL)Wilfried Ernst Erich Eberhardt, Thomas Christoph Gauler, Cecile Lepechoux, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonistsJihyae Ann, Aeran Jung, Mi-Yeon Kim, et al.
European Journal of Medicinal Chemistry|May 21, 2013
2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-regionShivaji A Thorat, Dong Wook Kang, HyungChul Ryu, et al.
Pageof 8